As reported in the literature, several studies have focused on OV, THCA, and LUAD, highlighting the positive correlation between SLC34A2 and tumor development (Shyian et al., 2011; Wang et al., 2015; He et al., 2020). Here, SLC34A2 is linked to neoplasm.